Hepatic Artery Infusion Therapy

Refer a patient
Request an appointment
Illustration of how HAI therapy works
Illustration of how HAI therapy works

The Division of Surgical Oncology is a veteran in treating metastatic colorectal cancer to the liver with hepatic artery infusion (HAI) therapy that delivers chemotherapy directly to the tumors from a pump implanted in the abdomen.

Clinical trials have demonstrated that HAI therapy — using floxuridine combined with systemic chemotherapy — increases survival rates for liver-predominant diseases, benefitting patients:

Local delivery of chemotherapy results in higher (up to 400 times more) concentrations in the tumors than delivery through a vein. WIth HAI therapy, the healthy parts of your liver continue to receive blood from a separate blood vessel, the portal vein. Thus, the treatment avoids damaging normal tissue and minimizes side effects elsewhere in your body.

Contact City of Hope® today to determine if HAI therapy is the right treatment for you.